| ²é¿´: 453 | »Ø¸´: 0 | |||
springsunyjÖÁ×ðľ³æ (ÎÄѧ̩¶·)
|
[½»Á÷]
2011Äê¶È£¨NSFC£©¡ª¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©½¡¿µÑо¿ºÏ×÷¼Æ»®ÏîÄ¿ÉêÇëÖ¸ÄÏ
|
|
2011Äê¶È¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á£¨NSFC£©¡ª¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©½¡¿µÑо¿ºÏ×÷¼Æ»®ÏîÄ¿ÉêÇëÖ¸ÄÏ -------------------------------------------------------------------------------- ×÷Õß:κÇÛ¡¡¡¡¡¡·¢±íʱ¼ä:2011-01-19¡¡¡¡¡¡Õª×Ô:¹ú¼ÊºÏ×÷¾Ö ¡¡¡¡ÎªÍƶ¯ºÍÖ§³ÖÎÒ¹ú¿ÆÑ§¼ÒÔÚ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÄ×ÊÖúÏÂÓë¼ÓÄôó¿ÆÑ§¼ÒÔÚÎÀÉúÁìÓòµÄ½»Á÷ÓëºÏ×÷£¬´Ù½øÖмÓÁ½¹ú´óѧ¡¢Ò½Ôº¡¢¿ÆÑÐÔºËù¼°Æä¸½Êô»ú¹¹¼ä¿ÆÑ§ºÏ×÷µÄ·¢Õ¹£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á£¨NSFC£©Óë¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©ÓÚ2005Äê12ÔÂÇ©Êð²¢ÓÚ2010Äê10ÔÂÐøÇ©Á˹ØÓÚ¿ªÕ¹½¡¿µÑо¿ºÏ×÷¼Æ»®µÄÁ½ⱸÍü¼¡£2006¡«2010Ä꣬˫·½Òѹ²Í¬×ÊÖú89¸öºÏ×÷Ñо¿ÏîÄ¿¡£ ¡¡¡¡2011Ä꣬ÖмÓË«·½½«¼ÌÐøÕ÷¼¯×ÊÖú¸Ã½¡¿µÑо¿ºÏ×÷¼Æ»®ÏîÄ¿£¬¾ßÌå˵Ã÷ÓëÒªÇóÈçÏ£º ¡¡¡¡Ò»¡¢ÏîĿ˵Ã÷ ¡¡¡¡£¨Ò»£©×ÊÖúÏîÄ¿Êý£º²»³¬¹ý15¸öÏîÄ¿£» ¡¡¡¡£¨¶þ£©ÏîĿִÐÐÆÚ£º3Ä꣨2012.1.1¡«2014.12.31£©£¬ÉêÇëÈËÐëÔÚÿÄêÄêÄ©Ìá½»ÏîÄ¿½øÕ¹±¨¸æ£¬ÏîĿִÐнáÊøºóÐëÌá½»½áÌⱨ¸æ¡£ ¡¡¡¡£¨Èý£©×ÊÖúÇ¿¶È£ºÖз½×î¸ß¶î¶È£º100ÍòÈËÃñ±Ò/3Äꣻ¼Ó·½×î¸ß¶î¶È£º22.5Íò¼ÓÔª/3Äê¡£ ¡¡¡¡£¨ËÄ£©×ÊÖúÁìÓò¼°Öз½ÏîÄ¿ÉêÇë´úÂ룺 ¡¡¡¡1) Neurosciences: to provide support for basic research in neuroscience, mental health, addiction and the senses.£¨ÉêÇë´úÂ룺H09£© ¡¡¡¡2) Diabetes and Obesity: to provide support for research on the measures, causes, prevention, treatment and consequences of diabetes and obesity.£¨ÉêÇë´úÂ룺H07£© ¡¡¡¡3) Cardiovascular System: to provide support for basic and translational research on the pathogenesis, treatment and ultimate of cardiovascular diseases, including myocardial infarction, stroke, cardiomyopathy and atherosclerosis.£¨ÉêÇë´úÂ룺H02£© ¡¡¡¡4) Cancer: to provide support for basic research on cancer genetics and epigenetics and tumor metastasis.£¨ÉêÇë´úÂ룺H16£© ¡¡¡¡5) Infection and Immunity: to provide support for basic research on viral and bacterial diseases and development of vaccines.£¨ÉêÇë´úÂ룺H10£© ¡¡¡¡6) Child and Youth Health: to provide support for research on fertility, pregnancy, maternal health, healthy child development and the etiology, prevention, and treatment of diseases in infants, children, and youth.£¨ÉêÇë´úÂ룺H04£© ¡¡¡¡7) Aging, Gerontology and Geriatrics: to encourage research on aging processes, on functional limitations in older adults as a consequence of disease, and on determinants of healthy aging within the context of one or more of the following priority areas: healthy and successful aging, biological mechanisms of aging, cognitive impairment in aging, aging and maintenance of functional autonomy, and health services relating to older people.£¨ÉêÇë´úÂ룺H25£© ¡¡¡¡8) Gender and Health: to provide support for research on biological considerations in reproductive health.£¨ÉêÇë´úÂ룺H04£© ¡¡¡¡9) Musculoskeletal Health and Arthritis: to provide support on one or more of the three strategic priorities such as: physical activity, mobility and health; tissue injury, repair and replacement; pain, disability and chronic disease. £¨ÉêÇë´úÂ룺H06£© ¡¡¡¡10) Genetics: to provide support for research on the human and other genomes and on all aspects of genetic, basic biochemistry and cell biology related to health and disease.£¨Îª±ãÓÚÏîÄ¿¹ÜÀí£¬ËùÓÐÒÅ´«Ñ§ÁìÓòµÄÏîÄ¿ÉêÇëÑ¡ÔñÉêÇë´úÂ룺H16£© ¡¡¡¡ÉêÇëÈËÐëÑ¡ÔñÒÔÉÏÁÐÃ÷µÄÉêÇë´úÂëÌîдÉêÇëÊ飨ÀýÈ磬Éñ¾¿ÆÑ§ÁìÓòÖ»Ìîд¡°H09¡±¼´¿É£¬ÎÞÐ迼ÂǾßÌåµÄÑо¿·½Ïò´úÂ룩£¬¶ÔÓÚδ°´ÒªÇóÌîдÒÔÉÏÖ¸¶¨ÉêÇë´úÂëµÄÉêÇëÊ飬½«²»ÓèÊÜÀí¡£ ¡¡¡¡¶þ¡¢ÉêÇëÒªÇó ¡¡¡¡£¨Ò»£©Öз½ÉêÇëÈËÓ¦¾ßÓи߼¶×¨Òµ¼¼ÊõÖ°Îñ£¨Ö°³Æ£©£»Ó¦ÊÇÕýÔڳе£»ò³Ðµ£¹ý3ÄêÆÚÒÔÉϹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿µÄ¸ºÔðÈË£¨ÔÚ¶Á²©Ê¿¼°²©Ê¿ºó¿ÉÒԲμÓÏîÄ¿Ñо¿£¬µ«²»µÃ×÷ΪÏîÄ¿µÄÉêÇëÈË£©¡£ ¡¡¡¡£¨¶þ£©ºÏ×÷Ñо¿Ó¦Ö÷ÒªÎ§ÈÆÌØ¶¨¿ÆÑ§ÎÊÌ⣻ּÔÚ¸ÄÉÆÈËÃñ½¡¿µÓëÉú»îÖÊÁ¿£»ÉêÇëÈËÓ¦Äܹ»³É¹¦ÊµÊ©ºÏ×÷Ñо¿£»³ä·Ö·¢»ÓºÏ×÷Ë«·½µÄ֪ʶר³¤£»Ôö½ø¿çѧ¿Æ¼äºÏ×÷£»¹ÄÀøÇàÄê¿ÆÑÐÈËÔ±²ÎÓë¡£ ¡¡¡¡£¨Èý£©Öз½ÉêÇëÈËÓ¦°´ÕÕ±¾ÏîÄ¿ÉêÇëÖ¸ÄϵÄÒªÇóÏòÎÒίÌá½»ÉêÇ룻¼Ó·½ºÏ×÷ÕßÓ¦°´ÕÕCIHR¹«²¼µÄÏîÄ¿ÉêÇëÖ¸ÄϵÄÒªÇóÏòCIHRÌá½»ÉêÇë¡£¶ÔÓÚµ¥·½Ìá½»µÄÉêÇ룬½«²»ÓèÊÜÀí¡£ ¡¡¡¡Èý¡¢ÏÞÏî¹æ¶¨ ¡¡¡¡±¾ÏîÄ¿ÊôÓÚ¹ú¼Ê£¨µØÇø£©ºÏ×÷Ñо¿ÏîÄ¿£¬Ðë×ñÑÒÔÏÂÏÞÏî¹æ¶¨£º ¡¡¡¡£¨Ò»£©ÉêÇëÈË£¨²»º¬²ÎÓëÕߣ©Í¬ÄêÖ»ÄÜÉêÇë1Ïî¹ú¼Ê£¨µØÇø£©ºÏ×÷Ñо¿ÏîÄ¿£» ¡¡¡¡£¨¶þ£©±¾ÏîÄ¿¼ÆÈë¾ßÓи߼¶×¨Òµ¼¼ÊõÖ°Îñ£¨Ö°³Æ£©µÄÈËÔ±ÉêÇ루°üÀ¨ÉêÇëÈ˺ÍÖ÷Òª²ÎÓëÕߣ©ºÍ³Ðµ££¨°üÀ¨¸ºÔðÈ˺ÍÖ÷Òª²ÎÓëÕߣ©ÏîÄ¿×ÜÊýÏÞ3ÏîµÄ·¶Î§£» ¡¡¡¡¹ØÓÚÏÞÏî¹æ¶¨µÄÏêϸ˵Ã÷£¬Çë¼û¡¶2011Äê¶È¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîĿָÄÏ¡·¡£ ¡¡¡¡ËÄ¡¢É걨˵Ã÷ ¡¡¡¡£¨Ò»£©Öз½ÉêÇëÈËÐëµÇ¼ISIS¿ÆÑ§»ù½ðÍøÂçϵͳ£¨http://isis.nsfc.gov.cn£©£¬ÔÚÏßÌ¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¹ú¼Ê£¨µØÇø£©ºÏ×÷Óë½»Á÷ÏîÄ¿ÉêÇëÊé¡·(ÒÔϼò³Æ¡°ÖÐÎÄÉêÇëÊ顱)¡£¾ßÌå²½ÖèÊÇ£ºÑ¡Ôñ¡°ÏîÄ¿¸ºÔðÈË¡±Óû§×éµÇ¼ϵͳ£¬½øÈëºóµã»÷¡°¹ú¼ÊºÏ×÷ÏîÄ¿ÉêÇ롱һÀ¸Öеġ°ÉêÇë¹ú¼ÊºÏ×÷ÀàÏîÄ¿¡±£¬ÔÙµã»÷¡°ÌîдÉêÇëÊ顱°´Å¥£¬ÔÚÏîÄ¿ÀàÐÍÖÐÑ¡Ôñ¡°ºÏ×÷Ñо¿¡±£¬µã»÷Õ¹¿ª×ÓÀà±ðºó£¬Ñ¡ÔñÏîÄ¿Ãû³Æ¡°NSFC-CIHRÏîÄ¿£¨Öмӣ©¡±£¬Çë°´ÕÕϵͳÌáʾÌîÈëÒ»¸öÉêÇëÈËÔø¾Ö÷³Ö¹ý»òÕýÔÚÖ÷³ÖµÄÈýÄêÆÚ£¨º¬£©ÒÔÉϹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿±àºÅ£¬Í¨¹ýϵͳÉóºËÖ®ºó£¬¼´¿É½øÈëÉêÇëÊéÌîд½çÃæ£¬ÔÚÏßÌîд²¢Ìá½»ÉêÇëÊé¡£ÖÐÎÄÉêÇëÊéÓ¦ÓëÓ¢ÎÄÉêÇëÊéµÄÄÚÈÝÒ»Ö¡£ ¡¡¡¡£¨¶þ£©ÉêÇëÈ˳ýÁËÌîдÌá½»ÖÐÎÄÉêÇëÊéÒÔÍ⣬ÐëÒÔ¸½¼þµÄÐÎʽÉÏ´«ÒÔÏÂÉ걨²ÄÁÏ£º ¡¡¡¡1¡¢Ó¢ÎÄÉêÇëÊ飨CHINA-CANADA Joint Health Research Initiative Proposal£©£ºÖз½ÉêÇëÈËÇëÔÚ±¾ÏîÄ¿Õ÷¼¯Ö¸Äϸ½¼þ²¿·ÖÏÂÔØÓ¢ÎÄÉêÇëÊ飬²¢Ñϸñ°´ÕÕÓ¢ÎÄÉêÇëÊé¸÷°æ¿é¾ßÌåµÄÒªÇó£¨ÈçÆª·ùÏÞÖÆ£©ÌîдӢÎÄÉêÇëÊ飬ÆäÖС°B2. Project Description¡±°æ¿éµÄÄÚÈݲ»Äܳ¬¹ý5Ò³¡£Ë«·½ÉêÇëÈËÌá½»µÄÓ¢ÎÄÉêÇëÊéÄÚÈÝÓ¦ÍêȫһÖ£¬¸ÃÏîÄ¿µÄͬÐÐÆÀÒ齫ÒÔ´ËÓ¢ÎÄÉêÇëÊéÄÚÈÝΪ׼¡£ ¡¡¡¡2¡¢¼Ó·½ºÏ×÷ÕßÏòCIHRÌá½»µÄÈ«Ì×Ó¢ÎÄÉêÇë²ÄÁÏ£¨Research Module¡¢Operating Budget ModuleºÍCommon CV°æ¿éÄÚÈÝ£©£¬Óɼӷ½ºÏ×÷ÕßÌîдÍê±Ïºó½«µç×Ó°æÌṩ¸øÖз½ÉêÇëÈË£¬²¢×÷ΪÖÐÎÄÉêÇëÊéµÄ¸½¼þÔÚISISϵͳÖÐÉÏ´«¡£ ¡¡¡¡3¡¢¼Ó·½ÉêÇëÈËÇ©ÊðµÄºÏ×÷È·ÈϺ¯£¨ºÏ×÷È·ÈϺ¯ÖÐÓ¦¶Ô´ËÏîÄ¿µÄÃû³Æ¡¢ºÏ×÷µ¥Î»¼°ÈËÔ±ÐÅÏ¢ÓèÒÔÃ÷ȷ˵Ã÷£©¡£ ¡¡¡¡£¨Èý£©ÔÚÏßÌîдÌá½»Íê±Ïºó£¬»¹Ðè´òÓ¡Ò»Ì×ISISϵͳÉú³ÉµÄ´øÓпÆÑ§²¿ÊÜÀíºÅµÄÖ½ÖÊÖÐÎÄÉêÇëÊ飬ǩ×Ö²¢¼Ó¸ÇÒÀÍе¥Î»¹«Õºó£¬Á¬Í¬±¾²¿·ÖµÚ£¨¶þ£©ÌõËùÁÐÉ걨²ÄÁÏÒ»²¢±¨Ë͹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðί¹ú¼ÊºÏ×÷¾ÖÃÀ´ó¼°¶«Å·´¦¡£ ¡¡¡¡Ö½ÖÊÉêÇë²ÄÁÏÐëÓëISISϵͳÖÐÌá½»µÄµç×Ó°æÉêÇë²ÄÁÏÍêȫһÖ¡£ ¡¡¡¡Îå¡¢ÏîÄ¿ÊÜÀí½ØÖ¹ÈÕÆÚ£º2011Äê3ÔÂ18ÈÕ£¨Ö½ÖÊÉêÇëÊéÒÔÓÊ´ÁΪ׼£©¡£ ¡¡¡¡×¢£ºÇëÉêÇëÈËÑϸñ×ñÕÕ±¾ÏîĿָÄϵĸ÷ÏîÒªÇóÌÉêÇ룬²»·ûºÏÉÏÊöÒªÇóµÄÉêÇ뽫ÎÞ·¨½øÈëÉóÅú³ÌÐò£¬ÊÓΪÎÞЧÉêÇë¡£¼Ó·½ÉêÇëÈËÇëµÇ¼¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©ÍøÕ¾°ìÀíÏîÄ¿ÉêÇëÊÖÐø¡£ ¡¡¡¡Áù¡¢ÁªÏµ·½Ê½£º ¡¡¡¡£¨Ò»£©ÏîÄ¿ÉêÇëÊÂÒË£º ¡¡¡¡µØ¡¡Ö·£º±±¾©Êк£µíÇøË«Çå·83ºÅ ¡¡¡¡¡¡¡¡¡¡¡¡¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¹ú¼ÊºÏ×÷¾ÖÃÀ´ó¼°¶«Å·´¦ ¡¡¡¡ÓÊ¡¡±à£º100085 ¡¡¡¡ÁªÏµÈË£ºÎºÇÛ ³Â»´ ¡¡¡¡µç¡¡»°£º010-62325544£»010-62327017 ¡¡¡¡´«¡¡Õ棺010-62327004 ¡¡¡¡µç¡¡ÓÊ£ºweiqin@nsfc.gov.cn£»chenhuai@nsfc.gov.cn ¡¡¡¡£¨¶þ£©Öз½ÉêÇëÈËÔÚÏßÌîдÉêÇëÊé¹ý³ÌÖÐÈçÓм¼ÊõÎÊÌ⣬¿ÉÁªÏµÎÒίISISϵͳ¼¼ÊõÖ§³Ö ¡¡¡¡µç¡¡»°£º010-62317474 ¡¡¡¡£¨Èý£©¼Ó·½ÉêÇëÈËÇëÓëCIHRÁªÏµ£¬ÁªÏµ·½Ê½ÈçÏ£º ¡¡¡¡1. For questions about this initiative and research objectives contact: ¡¡¡¡Dr. Elizabeth Th¨¦riault ¡¡¡¡Assistant Scientific Director ¡¡¡¡CIHR¡¯s Institute of Neurosciences, Mental Health and Addiction ¡¡¡¡Strangway Building ¡¡¡¡University of British Columbia ¡¡¡¡430 - 5950 University Blvd. ¡¡¡¡Vancouver, BC V6T 1Z3 ¡¡¡¡Telephone: +1-604-827-4744 ¡¡¡¡Fax: +1-604 827-3373 ¡¡¡¡Email: elizabeth.Theriault@ubc.ca ¡¡¡¡2. For questions on CIHR funding guidelines, how to apply, and the peer review process contact: ¡¡¡¡Dr. Christine Francoeur ¡¡¡¡Program Delivery Coordinator ¡¡¡¡Canadian Institutes of Health Research ¡¡¡¡Telephone: +1-613-952-4256 ¡¡¡¡Fax: +1-613-954-1800 ¡¡¡¡Email: christine.francoeur@cihr-irsc.gc.ca ¡¡¡¡¸½¼þ£ºÓ¢ÎÄÉêÇëÊ飨CHINA-CANADA Joint Health Research Initiative Proposal£© Á´½ÓµØÖ·£ºhttp://www.nsfc.gov.cn/Portal0/InfoModule_396/31601.htm |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ10È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´













»Ø¸´´ËÂ¥